Results 231 to 240 of about 2,444,315 (286)

Mechanical thrombolysis of acute ischemic stroke

Seminars in Cerebrovascular Diseases and Stroke, 2001
Chemical thrombolysis has been the mainstay of acute stroke treatment; however, these methods come with the risk of potentially lethal intracerebral hemorrhage. This article discusses the different methods of mechanical thrombolysis and other techniques used in the treatment of acute stroke, including angioplasty and stent placement.
Stanley L Barnwell, Gary M Nesbit
exaly   +3 more sources

Mechanical and Enzymatic Thrombolysis for Massive Pulmonary Embolism

Journal of Vascular and Interventional Radiology, 2002
To assess the efficacy and safety of mechanical fragmentation combined with intrapulmonary thrombolysis in massive pulmonary thromboembolism (PTE) with hemodynamic impairment.Fifty-nine patients diagnosed with massive PTE with hemodynamic impact were treated. The initial clinical symptoms were shock in 23 patients (38.9%), syncope in eight (13.5%), and
Miguel Angel de Gregório, M Fava, A Mainar   +2 more
exaly   +3 more sources

Mechanical Fragmentation and Pharmacologic Thrombolysis in Massive Pulmonary Embolism

Journal of Vascular and Interventional Radiology, 1997
PURPOSE: To evaluate the usefulness of mechanical fragmentation associated with intrapulmonary thrombolysis in acute massive pulmonary embolism (PE).PATIENTS AND METHODS: Sixteen cases of massive PE treated with mechanical fragmentation associated with ...
M Fava
exaly   +2 more sources

Some Aspects of the Mechanism of Thrombolysis

Thrombosis and Haemostasis, 1961
Summary1. Antibody to streptokinase and kinase, activator and plasmin inhibitors in the circulating blood of man, inhibit parenterally injected streptokinase and streptokinase-plasmin, in vivo. In vitro assays of these inhibitors determine the priming dose of streptokinase and streptokinase-plasmin to neutralize the inhibitors and effect thrombolysis.2.
A J, JOHNSON, W R, McCARTY
openaire   +2 more sources

Mechanisms of Thrombolysis

2001
The pharmacological use of plasminogen activators is associated with symptomatic improvement in patients with coronary artery thrombosis, peripheral arterial occlusions, and thrombosis of the venous system. Based on prospective angiographic studies and planned programs (1, 2, 3, 4, 5), thrombolysis is the only approved treatment of acute ischemic ...
Gregory J. Zoppo, Naohisa Hosomi
openaire   +1 more source

Mechanical intervention after thrombolysis

Journal of Cardiovascular Medicine, 2008
Revascularisation strategies for acute myocardial infarction have evolved from early admission to coronary care units, bed rest and cardiac rhythm monitoring, to thrombolytic therapy and primary angioplasty. Although mechanical intervention for a failed prior revascularisation attempt is common widespread clinical practice, the outcome of this two-step
Peels, Hans O. J., Anthonio, Rutger L., Jessurun, Gillian A. J., Zijlstra, Felix   +3 more
openaire   +3 more sources

Mechanisms of ultrasonic thrombolysis

2009 38th Annual Symposium of the Ultrasonic Industry Association (UIA), 2009
An ultrasonic transversely vibrating wire delivers energy to an active zone to facilitate thrombolysis in a blood vessel. Ultimately, all the energy delivered into the treatment region at the active zone ends up as heat. The heat created can originate from three sources.
Jeffrey J. Vaitekunas, Elvira Lang, Mark Schafer   +2 more
openaire   +1 more source

Percutaneous Mechanical Thrombolysis

Investigative Radiology, 1991
Schmitz-Rode T, Gunther RW. Percutaneous mechanical thrombolysis: a comparative study of various rotational catheter systems. Invest Radiol 1991;26:557-563. In vitro fragmentation of thrombi was performed with the Kensey catheter, the Bildsoe catheter, the Gunther aspiration catheter, and two modified aspiration catheters in a model circuit under ...
THOMAS SCHMITZ-RODE, ROLF W. G??NTHER
openaire   +1 more source

Successful thrombolysis on a mechanical tricuspid prosthesis

European Heart Journal, 1989
Recombinant tissue-type plasminogen activator (rt-PA) is presently used for the treatment of different clinical entities, mostly myocardial infarction. Its use for treatment of thrombotic dysfunction of prosthetic cardiac valves is more recent and has been only rarely reported.
M A, Prieto Palomino, M J, Ruiz de Elvira, F, Sanchez Llorente, E, Torrado, J L, Castillo, N, Gonzalez de Vega, A, Garijo Galve   +6 more
openaire   +2 more sources